(2E)-1-(2-methylphenyl)-3-[4-(propan-2-yl)phenyl]prop-2-en-1-one, 95.0%, 2g

3-Cyclohexylprop-2-ynoic acid, 97%, 1g

N-(2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)methanesulfonamide, 95.0%, 1g

Pentaerythritol triacrylate (tech) (stabilized with 200 - 600 ppm MEHQ), tech, 100g

Sal disódica de dimetilglioxima octahidratada, mínimo 98 %, pa, 50 g, envase de vidrio

tert-Butyl 2-hydroxypyrrolidine-1-carboxylate, 95.0%, 100mg

4-IODO-1,2-DIMETHYL-1H-IMIDAZOLE, 95.0%, 1g

N-ethyl-2-morpholin-4-ylethanamine, 95.0%, 1g

Benzo[b]thiophen-4-ol, 95.0%, 1g

(3aR,8aS)-2-(5-(Trifluoromethyl)pyridin-2-yl)-8,8a-dihydro-3aH-indeno[1,2-d]oxazole, ��97.0%, 250mg

2-Hydroxymethyl oxazole, 95.0%, 250mg

4-(Trifluoromethoxy)pyridin-2-amine, 98+%, 250mg

N-(1-Benzhydrylazetidin-3-yl)acetamide, 98+%, 1g